IGF1R and neoplasm: In agreement with this, it has been found that the inhibition of LUNAR1 in CRC decreases tumour growth and efficiently depletes IGF1 pathway activity, indicating a role for the LUNAR1/NOTCH1/IGF1R axis in cancer development [104].